X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
D | 2024-11-13 | VCEL | McLaughlin Kevin F | Dir | S - Sale+OE | $55.54 | -7,000 | 11,900 | -37% | -$388,780 | |||||
DM | 2024-11-13 | VCEL | Colangelo Dominick | Pres, CEO | S - Sale+OE | $54.75 | -35,000 | 220,937 | -14% | -$1,916,250 | |||||
DM | 2024-11-11 | VCEL | Zerbe Robert L Md | Dir | S - Sale+OE | $56.25 | -5,000 | 26,595 | -16% | -$281,250 | |||||
DM | 2024-10-16 | VCEL | Colangelo Dominick | Pres, CEO | S - Sale+OE | $40.86 | -35,000 | 220,937 | -14% | -$1,430,100 | |||||
D | 2024-10-16 | VCEL | Gilman Steven C | Dir | S - Sale+OE | $41.36 | -5,833 | 11,000 | -35% | -$241,253 | |||||
D | 2024-10-02 | VCEL | Gilman Steven C | Dir | S - Sale+OE | $40.35 | -5,833 | 11,000 | -35% | -$235,362 | |||||
D | 2024-10-01 | VCEL | Siegal Jonathan | Principal Accounting Officer | S - Sale+OE | $41.90 | -568 | 1,124 | -34% | -$23,799 | |||||
D | 2024-09-18 | VCEL | Gilman Steven C | Dir | S - Sale+OE | $45.54 | -5,834 | 11,000 | -35% | -$265,680 | |||||
DM | 2024-09-11 | VCEL | Colangelo Dominick | Pres, CEO | S - Sale+OE | $43.64 | -35,000 | 220,937 | -14% | -$1,527,225 | |||||
D | 2024-09-04 | VCEL | Gilman Steven C | Dir | S - Sale+OE | $48.58 | -5,000 | 11,000 | -31% | -$242,900 | |||||
D | 2024-09-03 | VCEL | Hopper Jonathan Mark | Chief Medical Officer | S - Sale+OE | $49.83 | -10,000 | 58,229 | -15% | -$498,300 | |||||
DM | 2024-08-14 | VCEL | Colangelo Dominick | Pres, CEO | S - Sale+OE | $45.71 | -35,000 | 220,937 | -14% | -$1,599,675 | |||||
D | 2024-08-07 | VCEL | McLaughlin Kevin F | Dir | S - Sale+OE | $45.94 | -7,000 | 11,900 | -37% | -$321,580 | |||||
DM | 2024-07-17 | VCEL | Colangelo Dominick | Pres, CEO | S - Sale+OE | $51.48 | -35,000 | 220,937 | -14% | -$1,801,625 | |||||
D | 2024-07-16 | VCEL | Flynn Sean C. | GC | S - Sale+OE | $52.18 | -15,000 | 707 | -95% | -$782,700 | |||||
2024-07-12 | VCEL | Mara Joseph Anthony Jr | CFO | S - Sale | $50.00 | -5,000 | 14,436 | -26% | -$250,000 | ||||||
2024-07-05 | VCEL | Siegal Jonathan | Principal Accounting Officer | S - Sale | $45.00 | -545 | 1,033 | -35% | -$24,525 | ||||||
DM | 2024-06-20 | VCEL | Flynn Sean C. | GC | S - Sale+OE | $45.11 | -15,000 | 487 | -97% | -$676,644 | |||||
DM | 2024-06-12 | VCEL | Colangelo Dominick | Pres, CEO | S - Sale+OE | $43.61 | -35,000 | 220,752 | -14% | -$1,526,350 | |||||
D | 2024-05-20 | VCEL | Hopper Jonathan Mark | Chief Medical Officer | S - Sale+OE | $49.99 | -10,000 | 58,116 | -15% | -$499,900 | |||||
DM | 2024-05-15 | VCEL | Colangelo Dominick | Pres, CEO | S - Sale+OE | $48.76 | -35,000 | 220,752 | -14% | -$1,706,600 | |||||
DM | 2024-04-17 | VCEL | Colangelo Dominick | Pres, CEO | S - Sale+OE | $45.53 | -35,000 | 195,307 | -15% | -$1,593,550 | |||||
D | 2024-03-27 | VCEL | Zerbe Robert L Md | Dir | S - Sale+OE | $51.57 | -3,278 | 23,395 | -12% | -$169,046 | |||||
DM | 2024-03-13 | VCEL | Colangelo Dominick | Pres, CEO | S - Sale+OE | $44.35 | -35,000 | 194,870 | -15% | -$1,552,075 | |||||
A | 2024-03-08 | VCEL | Flynn Sean C. | SVP, GC | S - Sale | $45.33 | -8,115 | 167 | -98% | -$367,853 | |||||
2024-03-11 | VCEL | Halpin Michael | COO | S - Sale | $44.71 | -7,874 | 949 | -89% | -$352,047 | ||||||
2024-03-07 | VCEL | Siegal Jonathan | Principal Accounting Officer | S - Sale | $45.00 | -1,634 | 1,400 | -54% | -$73,530 | ||||||
2024-03-08 | VCEL | Flynn Sean C. | SVP, GC | S - Sale | $45.33 | -8,115 | 167 | -98% | -$367,853 | ||||||
D | 2024-02-20 | VCEL | Zerbe Robert L Md | Dir | S - Sale+OE | $50.01 | -722 | 23,395 | -3% | -$36,107 | |||||
DM | 2024-02-14 | VCEL | Colangelo Dominick | Pres, CEO | S - Sale+OE | $47.92 | -35,000 | 174,008 | -17% | -$1,677,200 | |||||
2024-01-29 | VCEL | Zerbe Robert L Md | Dir | S - Sale | $44.22 | -2,300 | 23,395 | -9% | -$101,706 | ||||||
2024-01-25 | VCEL | Zerbe Robert L Md | Dir | S - Sale | $44.02 | -200 | 25,695 | -1% | -$8,804 | ||||||
D | 2024-01-22 | VCEL | Zerbe Robert L Md | Dir | S - Sale+OE | $41.85 | -8,000 | 25,895 | -24% | -$334,775 | |||||
DM | 2024-01-17 | VCEL | Colangelo Dominick | Pres, CEO | S - Sale+OE | $38.28 | -33,452 | 169,985 | -16% | -$1,280,375 | |||||
2024-01-12 | VCEL | Zerbe Robert L Md | Dir | S - Sale | $38.09 | -2,200 | 30,895 | -7% | -$83,798 | ||||||
M | 2023-12-13 | VCEL | Flynn Sean C. | SVP, GC | S - Sale | $34.42 | -1,538 | 4,467 | -26% | -$52,944 | |||||
2023-12-14 | VCEL | Wotton Paul K | Dir | S - Sale | $37.31 | -5,000 | 26,802 | -16% | -$186,550 | ||||||
DM | 2023-12-13 | VCEL | Colangelo Dominick | Pres, CEO | S - Sale+OE | $35.58 | -24,000 | 169,985 | -12% | -$853,800 | |||||
DM | 2023-12-06 | VCEL | Colangelo Dominick | Pres, CEO | S - Sale+OE | $34.14 | -24,397 | 176,742 | -12% | -$832,909 | |||||
D | 2023-11-30 | VCEL | Halpin Michael | COO | S - Sale+OE | $35.41 | -17,447 | 827 | -95% | -$617,798 | |||||
D | 2023-11-20 | VCEL | Hopper Jonathan Mark | Chief Medical Officer | S - Sale+OE | $36.40 | -5,000 | 53,007 | -9% | -$182,000 | |||||
2023-11-15 | VCEL | Zerbe Robert L Md | Dir | S - Sale | $38.02 | -300 | 33,095 | -1% | -$11,406 | ||||||
2023-11-15 | VCEL | Siegal Jonathan | Principal Accounting Officer | S - Sale | $37.70 | -662 | 1,305 | -34% | -$24,954 | ||||||
2023-07-14 | VCEL | Zerbe Robert L Md | Dir | S - Sale | $38.84 | -1,000 | 33,395 | -3% | -$38,840 | ||||||
2023-06-22 | VCEL | Zerbe Robert L Md | Dir | S - Sale | $36.00 | -3,000 | 34,395 | -8% | -$108,000 | ||||||
2023-02-02 | VCEL | Siegal Jonathan | Principal Accounting Officer | S - Sale | $31.00 | -330 | 675 | -33% | -$10,230 | ||||||
D | 2023-01-10 | VCEL | Colangelo Dominick | Pres, CEO | S - Sale+OE | $27.13 | -39,938 | 157,066 | -20% | -$1,083,598 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |